LMNA::NTRK1 fusion has also been implicated as the driver pathogenetic event in a wide spectrum of tumors of various lineages and risk of malignancies, including carcinomas, melanocytic Spitz lesions, as well as benign and malignant mesenchymal neoplasms [3, 17]. This evidence concerns the gene NTRK1 and carcinoma.